Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Indena claims colchicine derivatives

June 7, 1996

Manufacturing agreement for Neoprobe's RIGS/ACT activated cell therapy

June 7, 1996

Melanogenesis inhibitor revealed

June 7, 1996

Ongoing evaluation of Pharmacia & Upjohn's new water-soluble camptothecin derivative

June 7, 1996

New 5-FU molecular combination merits further study

June 7, 1996

Development of AccuSite for basal cell carcinoma delayed

June 7, 1996

Protein farnesyltransferase inhibitor from Banyu and Merck & Co.

May 31, 1996

Walter Reed Army Institute technology licensed to Jenner Technologies

May 31, 1996

Sandoz reports complex for radiotherapy of somatostatin receptor-positive cancers

May 31, 1996

OC104-26 identified as multidrug resistance (MDR)-reversing agent

May 31, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...